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Abstract
Background. Patients on dialysis mount reduced immune responses compared with the general
population. The Department of Health advises that these patients receive inﬂuenza and pneumococ-
cal vaccinations at regular intervals—once yearly and every ﬁve years, respectively. This article inves-
tigates the uptake of these vaccinations in this patient population and seeks to examine factors that
may inﬂuence vaccination status such as patient’s language and presence of a general practitioner
(GP) electronic vaccination reminder system. It also explores preferred site of vaccination for patients
and GPs as these are primary care vaccinations yet patients have more frequent contact with their
dialysis unit than their GP, blurring the boundaries between primary and specialized care.
Methods. This is a retrospective study of all patients registered as dialysing at the North Middlesex
University Hospital NHS Trust (NMUH) in September 2011. Information was obtained through GP
letters, GP and patient questionnaires.
Results. Of 154 patients, 133 were included in the data analysis. Nineteen per cent were up-to-
date with both vaccinations and 67% with their inﬂuenza vaccination. Fifty per cent had received
the inﬂuenza vaccination in the last two consecutive years. Thirty per cent were not up-to-date
with either vaccination. There was no evidence of a difference in uptake in 2009 (P = 0.7564) and in
2010 (P = 0.7435) among those who could and could not speak English. Twenty-ﬁve per cent of GPs
and 58.6% of patients preferred vaccination to occur in the dialysis unit. Unfortunately a high
number of GPs did not provide information on whether they used an electronic vaccination remin-
der but the analysis from the information provided by the few respondents did not reveal any corre-
lation between the presence of an electronic reminder and vaccination status.
Conclusion. Most dialysis patients were not up-to-date with both vaccinations. They were, however,
more up-to-date with their inﬂuenza than their pneumococcal vaccination. Non-English speakers
did not appear to be disadvantaged. GP electronic reminder systems may have inﬂuenced inﬂuenza
uptake but this study did not demonstrate a correlation and this is likely due to the lack of GP respon-
dents; the effectiveness of electronic reminders merits further studies as a tool to improve vacci-
nation rates in at-risk populations. Most patients visited their GP at least annually but preferred to
receive their vaccinations at the hospital. Vaccinating in the dialysis unit and maintaining an elec-
tronic record accessible to GPs or generating a letter for GPs may help ﬁll the vaccination gap in
these patients. Overall, more evidence is required for the effectiveness of such vaccinations and their
frequency, but in the meantime UK national guidelines were not being followed with a large pro-
portion of patients remaining unvaccinated against inﬂuenza and in particular pneumococcal
disease. This audit highlights the importance of local data collection, discussions around correlations
inﬂuencing outcomes and publication of results to improve standards of care at a national level.
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Introduction
Patients with end-stage renal failure (ESRF) mount a reduced
immune response to vaccination in comparison with the
general population because of their immunosuppressed
state. They have lower antibody titres than non-ESRF
patients [1, 2]. Although the pathophysiology behind the
attenuated T-cell-dependent antibody response to vacci-
nation is poorly understood, it is thought to be related to
high levels of uraemia. Despite decreased immunity in ESRF
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patients, the inﬂuenza vaccination has been shown to
reduce hospitalization and death in such patients [3].
However, data on the efﬁcacy and effectiveness of the 23-
valent Pneumococcal Polysaccharide Vaccine (PPV23) is
inconsistent, in particular in immunocompromised or high-
risk patients [4]. The 13-valent Pneumococcal Conjugate
Vaccine (PCV13) is recommended for use in children <2
years of age as it is more immunogenic in this population
but it protects against less pneumococcal strains than the
PPV23. Recent studies on immunogenicity of PCV13 in im-
munocompetent adults have led to a change in rec-
ommendation by the Centre for Disease Control to
vaccinate immunocompromised adults with PCV13 in
addition to PPV23 [5]. This policy has not yet been adopted
in the UK where PCV13 is still only recommended for
younger children [6].
Although the Department of Health (DOH) of the United
Kingdom (UK) recognizes that further evidence is required,
it currently recommends that patients with ESRF (includ-
ing dialysis patients) are vaccinated annually against in-
ﬂuenza and every ﬁve years against pneumococcal
disease with PPV23 [6, 7]. Adherence to these recommen-
dations is monitored by the DOH, which publishes national
data for inﬂuenza and pneumococcal vaccination uptake
per patient group on their website [8, 9].
UK guidelines suggest that patients with chronic renal
disease should be fully vaccinated against both inﬂuenza
and pneumococcus [6, 7, 10, 11]. In the UK, a national
programme is in place for general practitioners (GPs) to
vaccinate their patients against inﬂuenza. The inﬂuenza
vaccination is a Quality and Outcomes Framework (QOF)
indicator. The QOF scheme is a monetary annual reward
and incentive scheme for GPs based on National Institute
for Clinical Excellence guidance. Dialysis patients should
receive vaccinations at their GP practice, with optional
home delivery for patients with restricted mobility. Con-
fusingly, ESRF patients often receive blood-borne viral
hepatitis vaccinations in the hospital, at the low-clearance
clinic as part of the dialysis or transplantation work-up. In
addition, renal physicians on the dialysis unit often
provide general, non-renal-related healthcare. Sub-
sequently, it is not surprising that hospital dialysis patients
sometimes view their renal physicians as specialized GPs
and expect other health care needs to be coordinated
through the unit. A survey in Canada detailed how 54% of
renal physicians spent a third of their time providing
primary healthcare [12].
The aim of this study was to assess the level of inﬂuenza
and pneumococcal vaccination in a sample of patients on
dialysis compared with UK national data and to explore
factors that may have inﬂuenced vaccination uptake.
Methods
The study was conducted at the North Middlesex Univer-
sity Hospital NHS Trust (NMUH), a London District Hospital,
where dialysis is provided. A list of all 154 patients who
were dialysing at the NMUH in September 2011 before the
start of the vaccination season was obtained and the
NMUH IT services matched this list of patients with their
GPs using the hospital registration system. To obtain data
on vaccination status for each patient, their GP practices
(secretary and/or GP doctor) were contacted. Information
on whether patients had received inﬂuenza vaccinations
in 2009 and/or 2010 and the date for their last
pneumococcal vaccination was collected. Afterwards,
letters were sent to each GP practice reminding them of
the DOH guidelines for inﬂuenza and pneumococcal vacci-
nations in ESRF patients, together with a questionnaire
asking information on vaccination dates, availability of an
electronic database in place to remind to vaccinate a
speciﬁc group of patients, and their preference on where
patients in dialysis should be vaccinated (at the dialysis
unit or at the GP practice).
In addition, during their routine dialysis session,
patients were visited by doctors completing the audit who
ﬁlled in a questionnaire regarding the patients’ preferred
site of vaccination, their knowledge on which vaccinations
they should be receiving and other information related to
inﬂuenza and pneumococcal vaccination. The question-
naire was available only in English and therefore patients
who could not speak English and who were not
accompanied by a family member who could interpret did
not ﬁll the questionnaire. Reasons for not ﬁlling in the
questionnaire were recorded.
Statistical methods
Frequencies were calculated for the demographic data,
the information provided by the patients through the
questionnaire regarding their knowledge on vaccination
requirements and the data on pneumococcal and inﬂuen-
za vaccination uptake provided by the GP.
The 95% conﬁdence intervals for the proportion of
people who received vaccinations were calculated using
the ‘exact’ (Clopper–Pearson) method for proportions and
an equivalence test for the binomial proportion was per-
formed to assess whether the uptake of vaccinations
found in this study was statistically signiﬁcantly different
compared with that reported by the DOH in England.
Associations between categorical variables, such as vacci-
nation uptake and knowledge of the necessity of yearly
vaccinations, were evaluated using chi-square test and
Fisher exact tests (if expected frequencies were <5 in at
least one cell) and a Wilcoxon-Mann-Whitney test was
used to compare the median age in the different groups.
The association between the distribution of preferred vac-
cination site amongst patients and their GPs was assessed
using a Bhapkar’s test, to take into account the match
between patient and GP.
If the information was unavailable regarding whether a
patient had had a vaccination or not, the patient was con-
sidered not to have had it.
Analyses were performed using the SAS software
(version 9.3; SAS Institute, Cary, NC, USA). All tests of sig-
niﬁcance used two sided P-values <0.05 as the threshold
for statistical signiﬁcance.
Results
See Figure 1 for a summary of patients who took part in
the study.
Information on age, whether they were born outside
the UK, whether English was their ﬁrst language and
whether they could speak English was available for all 154
patients. One hundred and forty-three patients of the 154
patients were approached with a questionnaire. Eleven
were omitted as they had either died, had not attended
their dialysis slot during questionnaire distribution or had
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changed dialysis centre and could therefore not be inter-
viewed. Of 143, 10 did not speak English and therefore did
not take part as there was no interpreter available at the
time. One hundred and thirty-three patients were there-
fore included in the questionnaire analysis.
Characteristics of the patients who completed the ques-
tionnaire were summarized in Table 1. Of those who pro-
vided an answer, 73% were born outside of the UK, 53%
spoke English as a foreign language and 6% could not
speak English at all. The majority visited their GP more
than once a year (79%) and understood the necessity of
yearly vaccinations and only a small group (3.5%) deliber-
ately refused vaccination. Median age was 66 years of age
(interquartile range IR: 53–77) and signiﬁcantly differed
among those who were up-to-date with either one of the
two vaccinations, both or none (P = 0.0011).
GP details were collected for all patients except 21 of
them for the following reasons: the GP did not answer the
phone, fax or letter; the GP practice did not exist or could
not be located; patient died in between obtaining the list
and starting the audit; the patient was not registered with
a GP or at that practice. Therefore 133 were also included
in the data analysis. These patients were from a total of
75 different GP practices in Haringey and Enﬁeld, two rela-
tively deprived boroughs served by NMUH.
As is shown in Figure 2, 19% (n = 25) of the 133 patients
analysed were up-to-date with both vaccinations: they
had received an inﬂuenza vaccination within the last year,
and a pneumococcal vaccination within the last 5 years.
Thirty per cent (n = 40) of the patients were not up-to-
date with either vaccination, 48% (n = 64) were up-to-date
with the inﬂuenza vaccination alone (they had it in 2010)
and 3% (n = 4) were up-to-date with pneumococcal vacci-
nation alone (they had it within the last 5 years). Regard-
ing inﬂuenza vaccination (see Figure 3), 50% (n = 67) had
received it for the last 2 consecutive years, 20% (n = 27)
had not received it in 2009 or in 2010, while the rest had
received in similar proportions either in 2009 (13%) or in
2010 (17%). Regarding pneumococcal vaccination (see
Figure 4): 22% (n = 29) had received it in the last 5 years
while the rest had either not received it (including patients
who had received it but not within the past 5 years) or
data on pneumococcal status was lacking. The mean (and
median) time since the last pneumococcal vaccination in
the number of patients who had received it was 6 years
from 2011 (year 2005).
We compared our data with the national and regional
DOH data (see Table 2). We found that the NMUH dialysis
patients were signiﬁcantly more up-to-date with inﬂuenza
vaccinations than the corresponding national ESRF
average: in 2009/2010 63.2% (95% CI: 54.3–71.4) of
patients with ESRF attending NMUH received inﬂuenza
vaccination compared with 53.4% reported by DOH (P =
0.0241), and in 2010/11 66.9% (95% CI: 58.2–74.8) in
NMUH compared with 53% reported by DOH (P = 0.0013).
However, the ﬁgures for pneumococcal vaccination status
in the NMUH’s dialysis patients were signiﬁcantly lower (P
< 0.0001) than the national high-risk group: 21.8% (95%
CI: 15.1–29.8) in NMUH compared with 53% in 2011 in
England.
The proportion of patients who were up-to-date with in-
ﬂuenza vaccination among those who could and could
not speak English was not signiﬁcantly different: respect-
ively—in 2009 60.0% versus 63.4% (P = 1.0) and in 2010
50% versus 68% (P = 0.2978).
Of the 133 patients who answered the questionnaire,
53% understood that they needed yearly vaccinations.
There was no evidence of a signiﬁcant difference in inﬂu-
enza vaccination uptake in 2009 (P = 0.1182) and 2010
(P = 0.0665) among those who understood that they
needed yearly vaccinations and those who did not de-
monstrate that understanding. In 2009, 69% of those who
understood they needed yearly vaccination were vacci-
nated compared with 57% in those who did not and in
2010 the ﬁgures were 74% compared with 59%.
Administering timely inﬂuenza vaccination is a Clinical
Quality and Outcomes Framework (QOF) indicator, en-
couraging GPs to vaccinate their eligible patients. GP prac-
tices have developed systems to monitor and improve
their performance in meeting QOFs. Unfortunately a large
proportion of GPs (55%) did not answer our question re-
garding the presence or absence of electronic reminders
on their electronic database to alert them about speciﬁc
vaccination due dates. Thirty-nine per cent of GPs
answered that they did have an electronic reminder
system, and only 6% that they did not. There was no evi-
dence of a difference in inﬂuenza vaccination uptake
based on whether the GP had an electronic reminder or
did not provide an answer to this question (P = 0.7208).
The proportion of people vaccinated for inﬂuenza in the
past year was respectively 63.5, 62.5 and 69.9% in GP
practices with an electronic reminder, without an elec-
tronic reminder and where the GP did not reply.
We asked GPs and dialysis patients what their preferred
vaccination site would be and compared their answers
(see Table 1). Twenty-ﬁve per cent of GPs and 58.6% of
Fig. 1. Summary of patients and GPs who took part in the study.
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patients chose the dialysis unit as favourite site, 9% of GPs
and 16.5% of patients chose the GP surgery, 11% of GPs
and 10% of patients expressed no preference. Fifty-six per
cent of GPs and 11% of patients did not reply. These distri-
butions were statistically different between patient and
GPs (P < 0.0001). A recurring comment made by several
GPs was that they wanted to be updated on vaccination
status if vaccinations were to be given on the dialysis unit
for their own records.
Discussion
Evidence to support inﬂuenza and pneumococcal vacci-
nation in reducing morbidity and mortality in chronic
kidney disease populations is lacking, and further studies
are required. Current government policy, however, advises
that such target populations receive these vaccinations
regularly. GPs are required to maintain a database of all
eligible inﬂuenza vaccination recipients and the corre-
sponding QOF provides incentives for vaccination targets
to be met. Only 53% of ESRF patients had received their in-
ﬂuenza vaccinations in 2009 and another 53% in 2010
[13, 14]. The numbers were higher at the NMUH: 63% in
2009 and 67% in 2010 but only 50% had received a vacci-
nation in the last 2 consecutive years (i.e. yearly). The UK
recommends ﬁve yearly vaccination with PPV23 in ESRF
patients, despite lack of evidence regarding protective efﬁ-
cacy and antibody response in high-risk groups, including
optimal time interval between vaccinations. Uptake in our
dialysis patients was lower than the national average
(21.8% at NMUH versus national averages of 53% in at-
risk patients and 69.4% in >65 year olds). In total, only
19% of all dialysis patients at NMUH were up-to-date with
both vaccinations and 30% were not up-to-date with
either.
Table 1. Demographic characteristics and vaccination knowledge and preferences of the patients and information on preferences provided by GPs
(sample size is 133 unless stated differently)
Variable Overall
Up-to-date with
both vaccination
(n = 25)a
Only up-to-date
with either inﬂuenza
or pneumococcala
Not up-to-date
with both
vaccinationsa P-valueb
Patients
Age, (n = 154), median (IQR) 66 (53–77) 72 (62–75) 72 (58–79) 55 (46–67) 0.0011^
Born outside UK (n = 154), n(%)
Yes 113 (73)
Missing 0 (0)
English ﬁrst language (n = 154), n(%)
Yes 73 (47)
Missing 0 (0)
Non-English speaker (n = 154), n(%)
Yes 10 (6) 1 (4) 5 (7) 4 (7) 0.0887^^
Missing 11 (7) 0 (0) 0 (0) 0 (0)
Deliberately declined vaccination, (n = 154), n(%)
Yes 5 (3)
Missing 11 (7)
Frequency of GP visits, n(%)
More than once a year 104 (7)
About once a year 15 (11)
Less than once a year 10 (8)
Unsure 3 (2)
Missing 1 (0)
Understood necessity of yearly vaccination, n(%)
Yes 70 (60) 14 (56) 41 (60) 15 (37) 0.0676
Missing 0 (0) 0 (0) 0 (0) 0 (0)
Diseases they believed they needed protection against, n(%)
Flu mentioned (alone or in combination with other diseases) 61 (46)
Flu and pneumonia 7 (5)
Pneumonia (alone or in combination with other diseases) 9 (7)
Did not know 55 (41)
Missing 1 (0)
Preferred vaccination site for the dialysis patients, n(%)
dialysis unit 78 (59) 16 (64) 40 (59) 22 (55) <0.0001^^
GP surgery 22 (17) 3 (12) 11 (16) 8 (20)
No preference 13 (10) 3 (12) 7 (10) 3 (7)
Missing 20 (15) 3 (12) 10 (15) 7 (18)
GP
Preferred vaccination site for the GP, n(%)
dialysis unit 33 (25) 3 (12) 16 (24) 14 (35) <0.0001^^
GP surgery 12 (9) 4 (16) 8 (12) 0 (0)
No preference 14 (10) 3 (12) 6 (9) 5 (12)
Missing 74 (56) 15 (60) 38 (56) 21 (52)
Presence of electronic reminder, n(%)
Yes 52 (39) 10 (40) 25 (37) 17 (−42) 0.7325^^
No 8 (6) 0 (0) 5 (7) 3 (7)
Missing 73 (55) 15 (60) 38 (56) 20 (50)
aThe vaccination status could be determined only on the 133 patients who replied to the questionnaire. Because only four patients were up-to-date only
with pneumococcal vaccination, they have been merged with those who were up-to-date only with inﬂuenza vaccination.
bP-value comparing distributions across the three groups: those up-to-date with both vaccinations; with none; with one of the two vaccinations. If not
otherwise indicated a Chi-square test was used.
^Wilcoxon Mann Whitney test, ^^Fisher exact test.
30 S.M.S. Wilmore et al.
 at U
CL Library Services on July 24, 2014
http://ckj.oxfordjournals.org/
D
ow
nloaded from
 
Due to the high number of GPs who did not respond, a
lack of correlation between electronic reminders and vacci-
nation status must be interpreted with caution. The ques-
tion was asked whether GPs had an electronic reminder
system for inﬂuenza or pneumococcal vaccinations, and
was left unanswered in most cases. Unfortunately when
the GP answered ‘Yes’, we could not distinguish between in-
ﬂuenza or pneumococcal vaccinations, but it is highly likely
that these only referred to inﬂuenza alone, since these are
QOFs, and some GPs speciﬁcally added ‘ﬂu only’ to their
answers. It is difﬁcult to believe that an electronic reminder
had no effect, and this study did not manage to extrapolate
this data due to a lack of respondents and of clarity con-
cerning which vaccination the reminder addressed. Of note,
there was no clear and timely electronic reminder system
for each vaccination on the dialysis unit at NMH where an
electronic patient record system is in place.
Despite most dialysis patients (79%) visiting their GP
more than once a year, a majority (59%) of patients ex-
pressed their preference for vaccinations to be coordi-
nated through the dialysis unit where they spend a lot of
their time. Again, many (56%) GPs did not reply, but
among those who did, 60% (n = 33) also agreed that the
dialysis unit may be a better place for vaccination in this
high-risk group, provided that the GPs were informed.
NMUH uses a computerized electronic patient record
system, so inﬂuenza and pneumococcal status could be
added to this record. However for these additional and
timely vaccinations to occur on the dialysis unit funding
would be required to sustain the vaccination programme.
Vaccinating on the unit may be the best way of increasing
uptake in this speciﬁc population.
Not speaking English does not appear to be a barrier to ac-
cessing vaccination. Only 10 patients could not speak English,
and half were up-to-date with their vaccinations, comparable
with the uptake found in the rest of the population. Lan-
guages (other than English) spoken by renal physicians/
GPs were not recorded. A higher uptake of inﬂuenza vacci-
nation was observed among 53% of people whowere aware
of the yearly ﬂu vaccination, but this was not statistically sig-
niﬁcant, most likely because of lack of power. Very few were
aware of the necessity of the pneumococcal vaccination.
The dialysis cohort studied at the NMUH revealed inter-
esting ﬁndings regarding the uptake of inﬂuenza and
pneumococcal vaccinations in a high-risk group. Many
more patients were up-to-date with their inﬂuenza vacci-
nation than with their pneumococcal vaccination possibly
reﬂecting patient knowledge about the two illnesses. Only
one in ﬁve was up-to-date with both vaccinations and one
in three were not up-to-date with either despite a national
inﬂuenza programme, a QOF for inﬂuenza vaccinations
and clear DOH guidelines surrounding the two vacci-
nations. Uptake could be improved signiﬁcantly through-
out the UK and at the NMUH dialysis unit. One possible
strategy would be to provide these vaccinations on the
dialysis unit, with a clear electronic record of vaccination
status for each patient, and an automatically generated
letter to update the GP as information is entered onto the
Fig. 2. Pie-chart on uptake of inﬂuenza and pneumococcal vaccination
among participants in the study (n = 133). *Nine individuals had missing
values for one or both vaccinations. The missing values are treated as not
having the vaccination.
Fig. 4. Pie-chart on pneumococcal vaccination uptake (in the last 5 years)
among participants in the study (n = 133). ***Six individuals had missing
values for one or both vaccinations. The missing values are treated as not
having the vaccination.
Table 2. Inﬂuenza and pneumococcal vaccination status: England versus NMUH (n = 133)
England (Source: DOH [13, 14])
NMUH
<65 years at risk Speciﬁcally ESRF >65 years ESRF
Inﬂuenza vaccination status
2009/2010 51.6% (E 50.1%, H 50.7%) 53.4% (E 50.1%, H 49.5%) 72.4% (not broken down) 63.2% (11 missing)
2010/2011 50.4% (E 49.8%, H 44%) 53% (no data available by PCT) 72.8% (E 73.3%, H 71%) 66.9% (6 missing)
Pneumococcal vaccination status
2011 53% No data published for this group 69.4% 21.8% (6 missing)
E, Enﬁeld; H, Haringey.
Fig. 3. Pie-chart on inﬂuenza vaccination uptake among participants in
the study (n = 133). **Eleven individuals had missing values for one or both
vaccinations. The missing values are treated as not having the vaccination.
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patient’s dialysis electronic record. Funding would need to
be considered. Further studies are also required to provide
better evidence for such vaccinations in dialysis patients
and on the effectiveness of electronic reminders for GPs
and/or on dialysis units.
Key limitations may have impacted on the ﬁndings of
this study are as follows:
1. The sample size was relatively small, including 154
patients, due to the size of the dialysis unit. Neverthe-
less the response rate was good with 93% of the
patients taking part in the study. Unfortunately the GPs
were not as responsive as the patients.
2. For 21 patients no information was available from GPs.
Though to counter this limitation, this is a relatively
small proportion of those included.
3. The individuals who did not speak English, and sub-
sequently did not take part, may have provided valu-
able information should we have had appropriate
translators. Hence, though not feasible at the time, this
may represent a missed opportunity.
4. As 55% of GPs did not answer our question regarding
an electronic reminder, conclusions regarding this
potential intervention are built on relatively weak data.
5. The speciﬁc population we looked at is unlikely to be re-
presentative of the total UK dialysis population, par-
ticularly with reference to the high levels of individuals
born outside the UK and not having English as their
ﬁrst language. This could be seen as a potential weak-
ness, though could equally be seen as an interesting
group of patients, for whom such research is valuable
for improving care delivery.
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